Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy

Infectious Diseases in Obstetrics and Gynecology

Volumn 2013, Issue , 2013, Pages

  Taylor, Allan W ^a   Mosimaneotsile, Barudi ^b   Mathebula, Unami ^b   Mathoma, Anikie ^b   Moathlodi, Ritah ^b   Theebetsile, Irene ^b   Samandari, Taraz ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PLACEBO; PYRIDOXINE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN DEATH; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; STILLBIRTH; TUBERCULOSIS; AIDS RELATED COMPLEX; ANALYSIS OF VARIANCE; ANTIBIOTIC PROPHYLAXIS; CONTROLLED CLINICAL TRIAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANALYSIS OF VARIANCE; ANTIBIOTIC PROPHYLAXIS; ANTITUBERCULAR AGENTS; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HUMANS; ISONIAZID; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; TUBERCULOSIS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84875424497     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2013/195637     Document Type: Article

References (26)

1. Reid A., Scano F., Getahun H., Williams B., Dye C., Nunn P., de Cock K. M., Hankins C., Miller B., Castro K. G., Raviglione M. C., Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. The Lancet Infectious Diseases 2006 6 8 483 495 2-s2.0-33746326775 10.1016/S1473-3099(06)70549-7 (Pubitemid 44109811)
2. Samandari T., Agizew T. B., Nyirenda S., Tedla Z., Sibanda T., Shang N., Mosimaneotsile B., Motsamai O. I., Bozeman L., Davis M. K., Talbot E. A., Moeti T. L., Moffat H. J., Kilmarx P. H., Castro K. G., Wells C. D., 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. The Lancet 2011 377 9777 1588 1598 2-s2.0-79955694277 10.1016/S0140-6736(11)60204-3
3. Martinson N., Barnes G., Msandiwa R., Moulton L., Gray G., McIntyre J., Novel regimens for treating latent TB in HIV-infected adults in South Africa: a randomized clinical trial. Proceedings of the 16th Conference on Retroviruses and Opportunistic Infections 2009 Montreal, Canada abstract #36bLB
4. World Health Organization, Guidelines for Intensified Tuberculosis Case Finding and Isoniazid Preventive Therapy for People Living with HIV in Resource Constrained Settings 2011 Geneva, Switzerland World Health Organization
5. UNAIDS,. AIDS epidemic update, November 2009
6. Ojikutu B., Makadzange A. T., Gaolathe T., Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana. Current HIV/AIDS Reports 2008 5 2 94 98 2-s2.0-43249093378 10.1007/s11904-008-0015-3 (Pubitemid 351656423)
7. American Thoracic Society, Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recommendations and Reports 2000 49 RR06 1 54
8. Mosimaneotsile B., Mathoma A., Chengeta B., Nyirenda S., Agizew T. B., Tedla Z., Motsamai O. I., Kilmarx P. H., Wells C. D., Samandari T., Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a botswana experience, 2004-2006. Journal of Acquired Immune Deficiency Syndromes 2010 54 1 71 77 2-s2.0-77951697611 10.1097/QAI.0b013e3181c3cbf0
9. Snider D. E. Jr., Caras G. J., Isoniazid-associated hepatitis deaths: a review of available information. The American Review of Respiratory Disease 1992 145 2 494 497 2-s2.0-0026570896
10. Franks A. L., Binkin N. J., Snider D. E. Jr., Rokaw W. M., Becker S., Isoniazid hepatitis among pregnant and postpartum Hispanic patients. Public Health Reports 1989 104 2 151 155 2-s2.0-0024403618 (Pubitemid 19191644)
11. Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection-United States, 2004-2008. Morbidity and Mortality Weekly Report 59 8 224 229
12. Wilson E. A., Thelin T. J., Dilts P. V. Jr., Tuberculosis complicated by pregnancy. The American Journal of Obstetrics and Gynecology 1973 115 4 526 529 2-s2.0-0015923850
13. Scheinhorn D. J., Angelillo V. A., Antituberculous therapy in pregnancy. Risks to the fetus. Western Journal of Medicine 1977 127 3 195 198 2-s2.0-0017717819 (Pubitemid 8195582)
14. Kancherla V., Romitti P. A., Caspers K. M., Puzhankara S., Morcuende J. A., Epidemiology of congenital idiopathic talipes equinovarus in Iowa, 1997-2005. The American Journal of Medical Genetics A 2010 152 7 1695 1700 2-s2.0-77954134923 10.1002/ajmg.a.33481
15. Moorthi R. N., Hashmi S. S., Langois P., Canfield M., Waller D. K., Hecht J. T., Idiopathic talipes equinovarus (ITEV) (Clubfeet) in Texas. The American Journal of Medical Genetics 2005 132 4 376 380 2-s2.0-12944273482 10.1002/ajmg.a.30505 (Pubitemid 40175587)
16. Chung C. S., Nemechek R. W., Larsen I. J., Ching G. H., Genetic and epidemiological studies of clubfoot in Hawaii. General and medical considerations. Human Heredity 1969 19 4 321 342 2-s2.0-0014621539
17. Antiretroviral Pregnancy Registry Steering Committee, Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 Through 31 July 2009 2009 Wilmington, NC, USA Registry Coordinating Center
18. European Collaborative Study, Combination antiretroviral therapy and duration of pregnancy. AIDS 2000 14 18 2913 2920 10.1097/00002030-200012220- 00013 (Pubitemid 32042755)
19. Thorne C., Patel D., Newell M. L., Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004 18 17 2337 2339 2-s2.0-10244236453 10.1097/00002030- 200411190-00019 (Pubitemid 39620231)
20. Parekh N., Ribaudo H., Souda S., Chen J., Mmalane M., Powis K., Essex M., Makhema J., Shapiro R. L., Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana. International Journal of Gynecology and Obstetrics 2011 115 1 20 25 10.1016/j.ijgo.2011.04.008
21. Bussmann H., Wester C. W., Wester C. N., Lekoko B., Okezie O., Thomas A. M., DeGruttola S. M. V., Makhema J., Essex M., Marlink R. G., Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana. Journal of Acquired Immune Deficiency Syndromes 2007 45 3 269 273 2-s2.0-34347348169 10.1097/QAI.0b013e318050d683 (Pubitemid 47012372)
22. Tuomala R. E., Watts H., Li D., Vajaranant M., Pitt J., Hammill H., Landesman S., Zorrilla C., Thompson B., Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. Journal of Acquired Immune Deficiency Syndromes 2005 38 4 449 473 2-s2.0-15044363712 10.1097/01.qai. 0000139398.38236.4d (Pubitemid 40381556)
23. Tuomala R. E., Shapiro D. E., Mofenson L. M., Bryson Y., Culnane M., Hughes M. D., O'Sullivan M. J., Scott G., Stek A. M., Wara D., Bulterys M., Antiretroviral therapy during pregnancy and the risk of an adverse outcome. The New England Journal of Medicine 2002 346 24 1863 1870 2-s2.0-0037071791 10.1056/NEJMoa991159 (Pubitemid 34603030)
24. Kourtis A. P., Schmid C. H., Jamieson D. J., Lau J., Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 2007 21 5 607 615 2-s2.0-33847238368 10.1097/QAD.0b013e32802ef2f6
25. Stratton P., Tuomala R. E., Abboud R., Rodriguez E., Rich K., Pitt J., Diaz C., Hammill H., Minkoff H., Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1999 20 2 179 186 2-s2.0-0033081272 (Pubitemid 29063717)
26. Newell M. L., Dunn D. T., Peckham C. S., Semprini A. E., Pardi G., Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European collaborative study. AIDS 1996 10 14 1675 1681 2-s2.0-0029951260 (Pubitemid 26394986)